Arina ten Cate-Hoek

Assistant Professor

Dr Arina ten Cate-Hoek graduated as a medical doctor at the University of Amsterdam and as a Clinical Epidemiologist at the University of Maastricht. Her PhD thesis was on new developments in diagnosis and treatment of deep venous thrombosis. She currently holds a clinical position at the Heart+Vascular Center of Maastricht UMC+ and her specialty is in the prevention and treatment of venous thrombotic disease, especially the Post Thrombotic Syndrome. She is the medical director of the Anticoagulation Clinic as well as the medical coordinator of the Thrombosis Expertise Centre Maastricht. She gained some laboratory experience in the laboratory of the Harvard University Beth Israel Deaconess Medical Center in Boston and the Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB)in Amsterdam.

Since 2003, she has been working at the Maastricht UMC+ where she combines clinical work with clinical and translational research. The main topic of het research is prevention and treatment of the Post Thrombotic Syndrome. She received research grants mainly from ZonMw Efficiency research.

Department of Internal Medicine
P. Debyelaan 25, 6229 HX Maastricht
PO Box 612, 6200 MD Maastricht

  • 2020
    • Gulpen, A. J. W., van Dijk, J. K., Damen, N. L., ten Cate, H., Schalla, S., & Ten Cate-Hoek, A. J. (2020). Organisation of care for patients using direct oral anticoagulants. Netherlands Heart Journal, 28(9), 452-456. https://doi.org/10.1007/s12471-020-01436-8
    • Kremers, B., Wubbeke, L., Mees, B., ten Cate, H., Spronk, H., & ten Cate-Hoek, A. (2020). Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease A Systematic Review and Meta-Analysis. Arteriosclerosis Thrombosis and Vascular Biology, 40(9), 2018-2032. https://doi.org/10.1161/ATVBAHA.120.314774
    • Petersohn, S., Pouwels, X., Ramaekers, B., ten Cate-Hoek, A., & Joore, M. (2020). Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study. European Journal of Preventive Cardiology, 27(13), 1354-1365. https://doi.org/10.1177/2047487320913380
    • Leader, A., ten Cate, V., ten Cate-Hoek, A. J., Beckers, E. A. M., Spectre, G., Giaccherini, C., Gurevich-Shapiro, A., Krashin, E., Raanani, P., Schouten, H. C., Falanga, A., & ten Cate, H. (2020). Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment. European journal of internal medicine, 77, 86-96. https://doi.org/10.1016/j.ejim.2020.03.005
    • Ordieres-Ortega, L., Demelo-Rodriguez, P., Galeano-Valle, F., Kremers, B. M. M., ten Cate-Hoek, A. J., & ten Cate, H. (2020). Predictive value of D-dimer testing for the diagnosis of venous thrombosis in unusual locations: A systematic review. Thrombosis Research, 189, 5-12. https://doi.org/10.1016/j.thromres.2020.02.009
    • Notten, P., ten Cate-Hoek, A. J., Arnoldussen, C. W. K. P., Strijkers, R. H. W., de Smet, A. A. E. A., Tick, L. W., van de Poel, M. H. W., Wikkeling, O. R. M., Vleming, L-J., Koster, A., Jie, K-S. G., Jacobs, E. M. G., Ebben, H. P., Coppens, M., Toonder, I., ten Cate, H., & Wittens, C. H. A. (2020). Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. The Lancet Haematology , 7(1), E40-E49. https://doi.org/10.1016/S2352-3026(19)30209-1
  • 2019
    • Petersohn, S., Ramaekers, B. L. T., Olie, R. H., ten Cate-Hoek, A. J., Daemen, J-W. H. C., ten Cate, H., & Joore, M. A. (2019). Comparison of three generic quality-of-life metrics in peripheral arterial disease patients undergoing conservative and invasive treatments. Quality of Life Research, 28(8), 2257-2279. https://doi.org/10.1007/s11136-019-02166-0
    • Stolk, L. M., de Vries, F., Ebbelaar, C., de Boer, A., Schalekamp, T., Souverein, P., Hoek - ten Cate, A., & Burden, A. (2019). Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants (vol 83, pg 1835, 2017). British Journal of Clinical Pharmacology, 85(8), 1864-1864. https://doi.org/10.1111/bcp.14001
    • Gulpen, A. J. W., ten Cate, H., Henskens, Y. M. C., van Oerle, R., Wetzels, R., Schalla, S., Crijns, H. J., & ten Cate-Hoek, A. J. (2019). The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study. PLOS ONE, 14(6), [0217302]. https://doi.org/10.1371/journal.pone.0217302
    • Kremers, B. M. M., Birocchi, S., van Oerle, R., Zeerleder, S., Spronk, H. M. H., Mees, B. M. E., Luken, B. M., ten Cate, H., & ten Cate-Hoek, A. J. (2019). Searching for a Common Thrombo-Inflammatory Basis in Patients With Deep Vein Thrombosis or Peripheral Artery Disease. Frontiers in cardiovascular medicine, 6, 1-11. [33]. https://doi.org/10.3389/fcvm.2019.00033